Sage Therapeutics Inc Working Capital to Net Assets Ratio
Sage Therapeutics Inc working capital to net assets ratio. Sage Therapeutics Inc (SAGE) has a Working Capital to Net Assets ratio of 98.8% as of June 2025. Working capital of $364.44 Million (current assets of $409.08 Million minus current liabilities of $44.64 Million) is measured against net assets of $368.74 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Sage Therapeutics Inc (SAGE) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Sage Therapeutics Inc (2012–2024)
Working capital to net assets ratio of Sage Therapeutics Inc from 2012 to 2024. This chart shows how Sage Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of June 2025, the ratio stands at 98.8%, reflecting working capital of $364.44 Million against net assets of $368.74 Million USD. See operational self-sufficiency of Sage Therapeutics Inc to measure how many days the company can operate on defensive assets alone.
Sage Therapeutics Inc Working Capital to Net Assets Ratio by Year (2012–2024)
Sage Therapeutics Inc working capital to net assets ratio by year from 2012 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Sage Therapeutics Inc from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Sage Therapeutics Inc (SAGE) total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 98.8% | $459.69 Million | $465.09 Million | $531.30 Million | $71.61 Million | ▲ +0.5 pp |
| 2023 | 98.4% | $786.60 Million | $799.53 Million | $869.35 Million | $82.75 Million | ▲ +4.7 pp |
| 2022 | 93.7% | $1.17 Billion | $1.25 Billion | $1.27 Billion | $99.26 Million | ▼ -5.6 pp |
| 2021 | 99.2% | $1.72 Billion | $1.73 Billion | $1.80 Billion | $85.19 Million | ▲ +0.0 pp |
| 2020 | 99.2% | $2.06 Billion | $2.07 Billion | $2.12 Billion | $67.20 Million | ▲ +1.5 pp |
| 2019 | 97.7% | $922.97 Million | $944.65 Million | $1.04 Billion | $112.13 Million | ▼ -1.8 pp |
| 2018 | 99.5% | $858.66 Million | $862.97 Million | $944.70 Million | $86.03 Million | ▼ 0.0 pp |
| 2017 | 99.5% | $473.12 Million | $475.48 Million | $525.08 Million | $51.95 Million | ▼ -0.2 pp |
| 2016 | 99.7% | $367.41 Million | $368.52 Million | $402.58 Million | $35.17 Million | ▼ 0.0 pp |
| 2015 | 99.7% | $173.18 Million | $173.69 Million | $188.49 Million | $15.31 Million | ▲ +0.4 pp |
| 2014 | 99.3% | $121.06 Million | $121.89 Million | $128.82 Million | $7.76 Million | ▲ +118.6 pp |
| 2013 | -19.3% | $6.09 Million | $-31.54 Million | $8.41 Million | $2.31 Million | ▼ -8.8 pp |
| 2012 | -10.5% | $1.41 Million | $-13.39 Million | $2.83 Million | $1.42 Million | — |